3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Recurrent Rectal Cancer: new trials by email Literature Review of Recurrent Rectal Cancer trials Research Report on Recurrent Rectal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated bevacizumab, oxaliplatin, leucovorin calcium - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 3 | Completed | National Cancer Institute (NCI) | 880 | 2001-09-01 | 2013-01-24 |
| Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer irinotecan hydrochloride, oxaliplatin, leucovorin calcium - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 3 | Completed | National Cancer Institute (NCI) | 560 | 1999-11-01 | 2013-05-03 |
| Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer fluorouracil, eniluracil - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 3 | Completed | National Cancer Institute (NCI) | 950 | 1999-04-01 | 2013-01-24 |
Colonic Neoplasms (3) · Rectal Neoplasms (3)
Colonic Diseases (3) · Colorectal Neoplasms (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Rectal Diseases (3)
Fluorouracil (3) · Leucovorin (2) · Oxaliplatin (2) · Bevacizumab (1) · Irinotecan (1) · eniluracil (1)
National Cancer Institute (NCI) (3)
United States (3)
Bruce Giantonio (1) · Henry Pitot (1) · John Hines (1)
U10CA021115 (2), U10CA025224 (1)